We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DLB market cap is 7.58B. The company's latest EPS is USD 2.0994 and P/E is 37.79.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 375.89M | 298.37M | 290.56M | 315.57M | 364.52M |
| Operating Income | 109.22M | 15.94M | -3.49M | 66.22M | 108.97M |
| Net Income | 95.7M | 16.4M | 9.19M | 66.98M | 97.83M |
| Year End 29 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.24B | 1.16B | 1.28B | 1.25B | 1.3B |
| Operating Income | 257.08M | 218.74M | 330.52M | 206.61M | 215.75M |
| Net Income | 255.15M | 231.36M | 310.23M | 184.09M | 200.66M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.84B | 3.01B | 2.98B | 2.94B | 3.04B |
| Total Liabilities | 480.14M | 625.22M | 607.58M | 573.22M | 607.04M |
| Total Equity | 2.36B | 2.38B | 2.37B | 2.36B | 2.44B |
| Year End 29 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.82B | 2.92B | 3.11B | 2.69B | 2.98B |
| Total Liabilities | 508.72M | 478.92M | 501.46M | 438.53M | 607.58M |
| Total Equity | 2.31B | 2.44B | 2.6B | 2.25B | 2.37B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 160.94M | 282.07M | 367.08M | 8.41M | 189.82M |
| Investing | 51.89M | 73.92M | 54.21M | 633k | -17.24M |
| Financing | -157.19M | -194.01M | -236.81M | -125.14M | -169.3M |
| Year End 29 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M |
| Investing | -56.23M | 134.37M | -44.91M | -295.94M | 54.21M |
| Financing | -385.28M | -207.78M | -252.52M | -610.56M | -236.81M |
| Market Cap | 7.58B |
| Price to Earnings Ratio | 37.79 |
| Price to Sales Ratio | 5.83 |
| Price to Cash Ratio | 10.17 |
| Price to Book Ratio | 3.2 |
| Dividend Yield | 1.47% |
| Shares Outstanding | 95.58M |
| Average Volume (1 week) | 416.72k |
| Average Volume (1 Month) | 355.9k |
| 52 Week Change | -4.24% |
| 52 Week High | 91.015 |
| 52 Week Low | 75.87 |
| Spread (Intraday) | 0.79 (0.99%) |
| Company Name | Dolby Laboratories Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dolby.com |
| Industry | patent owners and lessors (6794) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
